Vifant Overview
- Founded
- 2015
- Status
- Private
- Latest Deal Type
- Grant
- Latest Deal Amount
- $225K
- Investors
- 2
Vifant General Information
Description
Developer of a mobile application designed to identify vision impairment in verbal, non-verbal and pre-verbal patients. The company's application uses the established principle of optico-kinetic nystagmus which is the eyes' reflexive, spontaneous response to moving patterns that does not need to be instructed or learned, enabling users to detect of vision problems early in a cost-effective way.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Application Software
Primary Office
- 3401 Grays Ferry Avenue
- Philadelphia, PA 19146
- United States
+1 (215) 000-0000
Vifant Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 01-Jan-2018 | $225K | Completed | Startup | ||
| 1. Accelerator/Incubator | 01-Sep-2015 | Completed | Startup |
Vifant Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Beth DeSouza | Chief Executive Officer | ||
| Det Ansinn | Chief Technology Officer | ||
| Monte Mills | Founder |
Vifant Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| America's Seed Fund | Government | 000 0000 | 000000 0 | ||
| UPstart | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |